Ignite Creation Date:
2025-12-24 @ 4:56 PM
Ignite Modification Date:
2026-05-23 @ 8:09 AM
Study NCT ID:
NCT00736450
Status:
TERMINATED
Last Update Posted:
2023-10-24
First Post:
2008-08-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Oblimersen Sodium & Combination Chemotherapy in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma
Sponsor:
University of Nebraska
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Contiguous Stage II Adult Diffuse Large Cell Lymphoma | View |
| None | Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma | View |
| None | Stage I Adult Diffuse Large Cell Lymphoma | View |
| None | Stage III Adult Diffuse Large Cell Lymphoma | View |
| None | Stage IV Adult Diffuse Large Cell Lymphoma | View |
Keywords: